The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CA15-3/MUC1 in CCTG MA-32 (NCT01101438): A phase III RCT of the effect of metformin vs. placebo on invasive disease free and overall survival in early stage breast cancer (BC).
 
Ryan JO Dowling
Employment - Roche (I)
 
Wendy R. Parulekar
Consulting or Advisory Role - Pfizer
 
Karen A. Gelmon
Consulting or Advisory Role - AstraZeneca; Merck; NanoString Technologies; Novartis; Pfizer
 
Lois E. Shepherd
No Relationships to Disclose
 
Shakeel Virk
No Relationships to Disclose
 
Marguerite Ennis
No Relationships to Disclose
 
Fangya Mao
No Relationships to Disclose
 
Jennifer A. Ligibel
No Relationships to Disclose
 
Dawn L. Hershman
No Relationships to Disclose
 
Priya Rastogi
No Relationships to Disclose
 
Ingrid A. Mayer
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis
Research Funding - Novartis; Pfizer
 
Timothy J. Hobday
Consulting or Advisory Role - Abbvie; Ipsen
Research Funding - Novartis (Inst)
 
Julie Lemieux
Honoraria - Myriad Genetics; Novartis
 
Alastair Mark Thompson
Honoraria - Novartis (I)
Research Funding - Genentech/Roche (Inst)
Travel, Accommodations, Expenses - Novartis (I)
 
Manuela Rabaglio-Poretti
No Relationships to Disclose
 
Timothy Joseph Whelan
No Relationships to Disclose
 
Vuk Stambolic
No Relationships to Disclose
 
Bingshu E. Chen
No Relationships to Disclose
 
Pamela Jean Goodwin
Consulting or Advisory Role - Novo Nordisk